2120
We observed transient panhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with prednisolone and cyclophosphamide.
 a patient with neuropsychiatric SLE: Subject; transient panhypogammaglobulinaemia: Effect; prednisolone and cyclophosphamide: Treatment; prednisolone: Treatment.Drug; cyclophosphamide: Treatment.Drug; neuropsychiatric SLE: Treatment.Disorder; prednisolone: Combination.Drug; cyclophosphamide: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with neuropsychiatric SLE: Subject; transient panhypogammaglobulinaemia: Effect; prednisolone and cyclophosphamide: Treatment; prednisolone: Treatment.Drug; cyclophosphamide: Treatment.Drug; neuropsychiatric SLE: Treatment.Disorder; prednisolone: Combination.Drug; cyclophosphamide: Combination.Drug